Neuralink PRIME study interim safety report
The report discloses electrode channel attrition among early participants; most channels remained stable while a minority showed gradual signal degradation.
Neuralink
2 entries7 月 2026
Neuralink expands PRIME trial enrollment to eight participants
Neuralink disclosed expanded enrollment in its PRIME early feasibility study, with early participants sustaining over a year of stable device operation.